Margaret T. Morris Professor of Health Care Policy, Emeritus
Friction in the Path to Use of Biosimilar Drugs. N Engl J Med. 2018 Mar 01; 378(9):791-793.
Friction in the Path to Use of Biosimilar Drugs.
DeKosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC
Alzheimer's & dementia : the journal of the Alzheimer's Association
Revision of the criteria for Alzheimer’s disease: A symposium. Alzheimers Dement. 2011 Jan; 7(1):e1-12.
Revision of the criteria for Alzheimer’s disease: A symposium.
Thal L, Kuller L, Bowman K, Breitner J, Evans D, Farrer L, Frank R, Khachaturian AS, Khachaturian ZS, Kukull W, Nieto J, Petersen R, Sager M, Scherr P, Bain LJ
The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia. Alzheimers Dement. 2007 Jan; 3(1):62-7.
The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia.
Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP
18F-florbetapir Positron Emission Tomography-determined Cerebral ß-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. 2018 04; 128(4):728-744.
18F-florbetapir Positron Emission Tomography-determined Cerebral ß-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.
Trends in mental health cost growth: an expanded role for management? Health Aff (Millwood). 2009 May-Jun; 28(3):649-59.
Trends in mental health cost growth: an expanded role for management?
Health insurance exchanges--making the markets work. N Engl J Med. 2009 Sep 17; 361(12):1135-7.
Health insurance exchanges--making the markets work.
Horvitz-Lennon M, Frank RG, Thompson W, Baik SH, Alegría M, Rosenheck RA, Normand SL
Investigation of racial and ethnic disparities in service utilization among homeless adults with severe mental illnesses. Psychiatr Serv. 2009 Aug; 60(8):1032-8.
Investigation of racial and ethnic disparities in service utilization among homeless adults with severe mental illnesses.
The journal of mental health policy and economics
The impact of mental health on labour market outcomes in China. J Ment Health Policy Econ. 2009 Sep; 12(3):157-66.
The impact of mental health on labour market outcomes in China.
Review: the net benefits of depression management in primary care. Med Care Res Rev. 2010 Jun; 67(3):251-74.
Review: the net benefits of depression management in primary care.
Work Requirements in Medicaid for People With Mental Illnesses and Substance Use Disorders. Psychiatr Serv. 2018 06 01; 69(6):626-627.
Work Requirements in Medicaid for People With Mental Illnesses and Substance Use Disorders.
Ojeda VD, Frank RG, McGuire TG, Gilmer TP
Mental illness, nativity, gender and labor supply. Health Econ. 2010 Apr; 19(4):396-421.
Mental illness, nativity, gender and labor supply.
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H
Proceedings of the National Academy of Sciences of the United States of America
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90.
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.
Making the Opioid Public Health Emergency Effective. JAMA Psychiatry. 2018 08 01; 75(8):767-768.
Making the Opioid Public Health Emergency Effective.
Frank RG, Berndt ER, Busch AB, Lehman AF
The Quarterly review of economics and finance : journal of the Midwest Economics Association
QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY* Q Rev Econ Finance. 2004 Jul; 44(3):390-409.
QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY*
Regulation of follow-on biologics. N Engl J Med. 2007 Aug 30; 357(9):841-3.
Huskamp HA, West JC, Rae DS, Rubio-Stipec M, Regier DA, Frank RG
Part D and dually eligible patients with mental illness: medication access problems and use of intensive services. Psychiatr Serv. 2009 Sep; 60(9):1169-74.
Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.
Government commitment and regulation of prescription drugs. Health Aff (Millwood). 2003 May-Jun; 22(3):46-8.
Government commitment and regulation of prescription drugs.
Essock SM, Drake RE, Frank RG, McGuire TG
Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question. Schizophr Bull. 2003; 29(1):115-23.
Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question.
Bauer AM, Azzone V, Goldman HH, Alexander L, Unützer J, Coleman-Beattie B, Frank RG
Implementation of collaborative depression management at community-based primary care clinics: an evaluation. Psychiatr Serv. 2011 Sep; 62(9):1047-53.
Implementation of collaborative depression management at community-based primary care clinics: an evaluation.
Ramalingam SS, Blackhall F, Krzakowski M, Barrios CH, Park K, Bover I, Seog Heo D, Rosell R, Talbot DC, Frank R, Letrent SP, Ruiz-Garcia A, Taylor I, Liang JQ, Campbell AK, O'Connell J, Boyer M
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2012 Sep 20; 30(27):3337-44.
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
Supported employment: evidence on economic impacts. Psychiatr Serv. 2013 Feb 01; 64(2):103.
Supported employment: evidence on economic impacts.
Araya R, Rojas G, Fritsch R, Frank R, Lewis G
Inequities in mental health care after health care system reform in Chile. Am J Public Health. 2006 Jan; 96(1):109-13.
Inequities in mental health care after health care system reform in Chile.
Horvitz-Lennon M, Normand SL, Frank RG, Goldman HH
"Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes. Am J Psychiatry. 2003 Apr; 160(4):720-6.
"Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes.
Friction in the Path to Use of Biosimilar Drugs. N Engl J Med. 2018 05 31; 378(22):2148.
Looking for truth in all the wrong places. Med Care. 2005 Aug; 43(8):751-2.
Looking for truth in all the wrong places.
What is the empirical basis for paying for quality in health care? Med Care Res Rev. 2006 Apr; 63(2):135-57.
What is the empirical basis for paying for quality in health care?
Busch AB, Lehman AF, Goldman H, Frank RG
Changes over time and disparities in schizophrenia treatment quality. Med Care. 2009 Feb; 47(2):199-207.
Changes over time and disparities in schizophrenia treatment quality.
Busch AB, Frank RG, Lehman AF, Greenfield SF
Administration and policy in mental health
Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out. Adm Policy Ment Health. 2006 May; 33(3):388-97.
Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out.
O'Malley AJ, Frank RG, Kaddis A, Rothenberg BM, McNeil BJ
Impact of alternative interventions on changes in generic dispensing rates. Health Serv Res. 2006 Oct; 41(5):1876-94.
Impact of alternative interventions on changes in generic dispensing rates.
Swartz K, Ayanian JZ, Soumerai SB, Epstein AM, Blumenthal D, McNeil BJ, Frank RG
Cures for an ailing system. Newsweek. 2007 Dec 10; 150(24):78, 80, 82 passim.
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. Psychopharmacol Bull. 2009; 42(1):35-49.
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing.
Price RA, Frank RG, Cleary PD, Goldie SJ
Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests. Med Care. 2011 Feb; 49(2):132-8.
Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests.
Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar; 5(2):85-92.
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
Reflections on the Mental Health Parity and Addiction Equity Act After 10 Years. Milbank Q. 2018 12; 96(4):615-618.
Reflections on the Mental Health Parity and Addiction Equity Act After 10 Years.
Azzone V, Frank RG, Normand SL, Burnam MA
Effect of insurance parity on substance abuse treatment. Psychiatr Serv. 2011 Feb; 62(2):129-34.
Effect of insurance parity on substance abuse treatment.
The Trump Administration's Actions to Address the Opioids Public Health Crisis-Reply. JAMA Psychiatry. 2019 01 01; 76(1):101-102.
The Trump Administration's Actions to Address the Opioids Public Health Crisis-Reply.
Managed care and systems cost-effectiveness: treatment for depression. Med Care. 2005 Dec; 43(12):1225-33.
Managed care and systems cost-effectiveness: treatment for depression.
Changes in mental health financing since 1971: implications for policymakers and patients. Health Aff (Millwood). 2006 May-Jun; 25(3):601-13.
Changes in mental health financing since 1971: implications for policymakers and patients.
Landon BE, Rosenthal MB, Normand SL, Frank RG, Epstein AM
Quality monitoring and management in commercial health plans. Am J Manag Care. 2008 Jun; 14(6):377-86.
Quality monitoring and management in commercial health plans.
Shuffling toward parity--bringing mental health care under the umbrella. N Engl J Med. 2008 Jul 10; 359(2):113-5.
Shuffling toward parity--bringing mental health care under the umbrella.
Mental illness, work, and income support programs. Am J Psychiatry. 2009 Apr; 166(4):398-404.
Mental illness, work, and income support programs.
Better but not best: recent trends in the well-being of the mentally ill. Health Aff (Millwood). 2009 May-Jun; 28(3):637-48.
Better but not best: recent trends in the well-being of the mentally ill.
Horvitz-Lennon M, McGuire TG, Alegria M, Frank RG
Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia. Health Serv Res. 2009 Dec; 44(6):2106-22.
Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia.
Specialty care medical homes for people with severe, persistent mental disorders. Health Aff (Millwood). 2010 May; 29(5):867-73.
Specialty care medical homes for people with severe, persistent mental disorders.
Petrylak DP, Kantoff P, Vogelzang NJ, Mega A, Fleming MT, Stephenson JJ, Frank R, Shore ND, Dreicer R, McClay EF, Berry WR, Agarwal M, DiPippo VA, Rotshteyn Y, Stambler N, Olson WC, Morris SA, Israel RJ
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer. Prostate. 2019 05; 79(6):604-613.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Making Choice and Competition Work in Individual Insurance in Health Reform Proposals. Issue Brief (Commonw Fund). 2019 01 01; 2019:1-11.
Making Choice and Competition Work in Individual Insurance in Health Reform Proposals.
The impact of expanded Medicaid eligibility on access to naloxone. Addiction. 2019 09; 114(9):1567-1574.
The impact of expanded Medicaid eligibility on access to naloxone.
Market Concentration and Potential Competition in Medicare Advantage. Issue Brief (Commonw Fund). 2019 Feb 01; 2019:1-8.
Market Concentration and Potential Competition in Medicare Advantage.
Harvard T.H. Chan School of Public Health
Professor of Health Care Policy, Emeritus
Professor of Health Care Policy (on sabbatical)
Professor of Health Economics in the Department of Health Care Policy, Emeritus
Henry J. Kaiser Professor of Health Care Policy (on sabbatical)
Daniel C. Tosteson Professor of Health Care Policy, Emeritus
Huntley Quelch Professor of Health Care Economics
John H. Foster Professor of Health Policy and Management
Gluck WL, Gounder MM, Frank R, Eskens F, Blay JY, Cassier PA, Soria JC, Chawla S, de Weger V, Wagner AJ, Siegel D, De Vos F, Rasmussen E, Henary HA
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma. Invest New Drugs. 2020 06; 38(3):831-843.
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.
Unruh MA, Stevenson DG, Frank RG, Cohen MA, Grabowski DC
Demand-Side Factors Associated with the Purchase of Long-Term Care Insurance. Forum Health Econ Policy. 2016 Jun 01; 19(1):23-43.
Demand-Side Factors Associated with the Purchase of Long-Term Care Insurance.
Medicare Drug-Price Negotiation - Why Now . . . and How. N Engl J Med. 2019 Oct 10; 381(15):1404-1406.
Medicare Drug-Price Negotiation - Why Now . . . and How.
Changing Medicare's Protected Classes: History, Mistrust, and Budgets in the Prescription Drug Market. Psychiatr Serv. 2019 10 01; 70(10):858-859.
Changing Medicare's Protected Classes: History, Mistrust, and Budgets in the Prescription Drug Market.
Reflections on the Link Between Income During Childhood and Risk of Developing Schizophrenia. JAMA Psychiatry. 2020 01 01; 77(1):11-12.
Reflections on the Link Between Income During Childhood and Risk of Developing Schizophrenia.
In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants. Health Aff (Millwood). 2019 12; 38(12):2048-2056.
In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
Abuses of FDA Regulatory Procedures - The Case of Suboxone. N Engl J Med. 2020 Feb 06; 382(6):496-498.
Abuses of FDA Regulatory Procedures - The Case of Suboxone.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Generic Drug Policy and Suboxone to Treat Opioid Use Disorder. J Law Med Ethics. 2019 12; 47(4_suppl):43-53.
Generic Drug Policy and Suboxone to Treat Opioid Use Disorder.
Addiction Treatment: The Authors Reply. Health Aff (Millwood). 2020 04; 39(4):722.
Patrick SW, Frank RG, McNeer E, Stein BD
Improving the Child Welfare System to Respond to the Needs of Substance-Exposed Infants. Hosp Pediatr. 2019 08; 9(8):651-654.
Improving the Child Welfare System to Respond to the Needs of Substance-Exposed Infants.
The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines. Med Care Res Rev. 2021 10; 78(5):585-590.
The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Behavioral Health Parity Efforts in the US. JAMA. 2020 Aug 04; 324(5):447-448.
Behavioral Health Parity Efforts in the US.
Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML
Therapies Offered at Residential Addiction Treatment Programs in the United States. JAMA. 2020 Aug 25; 324(8):804-806.
Therapies Offered at Residential Addiction Treatment Programs in the United States.
Jobs for People With Mental Health Conditions: Trends and Prospects. Psychiatr Serv. 2021 02 01; 72(2):143-147.
Jobs for People With Mental Health Conditions: Trends and Prospects.
The Russell Sage Foundation journal of the social sciences : RSF
Medicaid Expansion's Spillover to the Criminal Justice System: Evidence from Six Urban Counties. RSF. 2020 Jul; 6(2):244-263.
Medicaid Expansion's Spillover to the Criminal Justice System: Evidence from Six Urban Counties.
Inquiry : a journal of medical care organization, provision and financing
Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization. Inquiry. 2020 Jan-Dec; 57:46958020981462.
Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization.
Alegría M, Frank RG, Hansen HB, Sharfstein JM, Shim RS, Tierney M
Transforming Mental Health And Addiction Services. Health Aff (Millwood). 2021 02; 40(2):226-234.
Transforming Mental Health And Addiction Services.
Mohr DC, Azocar F, Bertagnolli A, Choudhury T, Chrisp P, Frank R, Harbin H, Histon T, Kaysen D, Nebeker C, Richards D, Schueller SM, Titov N, Torous J, Areán PA
Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment. Psychiatr Serv. 2021 06; 72(6):677-683.
Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.
Addressing the Risk of Medicare Trust Fund Insolvency. JAMA. 2021 Jan 26; 325(4):341-342.
Addressing the Risk of Medicare Trust Fund Insolvency.
Journal of health politics, policy and law
Policy Responses to the Addiction Crisis. J Health Polit Policy Law. 2021 08 01; 46(4):585-597.
Policy Responses to the Addiction Crisis.
Admission Practices And Cost Of Care For Opioid Use Disorder At Residential Addiction Treatment Programs In The US. Health Aff (Millwood). 2021 02; 40(2):317-325.
Admission Practices And Cost Of Care For Opioid Use Disorder At Residential Addiction Treatment Programs In The US.
The Evolution of Supply and Demand in Markets for Generic Drugs. Milbank Q. 2021 09; 99(3):828-852.
The Evolution of Supply and Demand in Markets for Generic Drugs.
Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic. Health Aff (Millwood). 2021 06; 40(6):904-909.
Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.
Behavioral health carve-outs: Do they impede access or prioritize the neediest? Health Serv Res. 2021 10; 56(5):802-804.
Behavioral health carve-outs: Do they impede access or prioritize the neediest?
Lessons From the COVID-19 Pandemic on the Nature of Work Among Those With Mental Illness. Psychiatr Serv. 2022 05; 73(5):596-598.
Lessons From the COVID-19 Pandemic on the Nature of Work Among Those With Mental Illness.
COMMENTARY: Medicaid Expansion and Mental Health Care and Coverage. J Ment Health Policy Econ. 2021 Sep 01; 24(3):97-99.
COMMENTARY: Medicaid Expansion and Mental Health Care and Coverage.
Paying for Cancer Drugs That Prove Their Benefit. JAMA. 2021 Oct 26; 326(16):1579-1580.
Paying for Cancer Drugs That Prove Their Benefit.
Regulating Drug Prices while Increasing Innovation. N Engl J Med. 2021 Nov 18; 385(21):1921-1923.
Regulating Drug Prices while Increasing Innovation.
Frank RG, Shahzad M, Kesselheim AS, Feldman W
Biosimilar competition: Early learning. Health Econ. 2022 04; 31(4):647-663.
Assessing the long-term effects of Basic Medical Insurance on catastrophic health spending in China. Health Policy Plan. 2022 Jun 13; 37(6):747-759.
Assessing the long-term effects of Basic Medical Insurance on catastrophic health spending in China.
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis. Addiction. 2022 05; 117(5):1198-1199.
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis.
Toward Greater Accountability in Mental Health Care. Psychiatr Serv. 2023 02 01; 74(2):182-187.
Toward Greater Accountability in Mental Health Care.
International Reference Pricing in the Context of US Drug Policy. J Health Polit Policy Law. 2022 12 01; 47(6):779-796.
International Reference Pricing in the Context of US Drug Policy.
Our Other Epidemic: Addiction. JAMA Health Forum. 2021 Mar 01; 2(3):e210273.
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials. Health Aff (Millwood). 2022 09; 41(9):1273-1280.
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials.
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation? JAMA Health Forum. 2021 12 03; 2(12):e214242.
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?
Drug Development-Social and Private Returns. JAMA Health Forum. 2023 Jul 07; 4(7):e231309.
Drug Development-Social and Private Returns.
O'Connor RC, Worthman CM, Abanga M, Athanassopoulou N, Boyce N, Chan LF, Christensen H, Das-Munshi J, Downs J, Koenen KC, Moutier CY, Templeton P, Batterham P, Brakspear K, Frank RG, Gilbody S, Gureje O, Henderson D, John A, Kabagambe W, Khan M, Kessler D, Kirtley OJ, Kline S, Kohrt B, Lincoln AK, Lund C, Mendenhall E, Miranda R, Mondelli V, Niederkrotenthaler T, Osborn D, Pirkis J, Pisani AR, Prawira B, Rachidi H, Seedat S, Siskind D, Vijayakumar L, Yip PSF
Gone Too Soon: priorities for action to prevent premature mortality associated with mental illness and mental distress. Lancet Psychiatry. 2023 06; 10(6):452-464.
Gone Too Soon: priorities for action to prevent premature mortality associated with mental illness and mental distress.
Lasting scars: The impact of depression in early adulthood on subsequent labor market outcomes. Health Econ. 2023 12; 32(12):2694-2708.
Lasting scars: The impact of depression in early adulthood on subsequent labor market outcomes.
Improving Labor Outcomes among People with Mild or Moderate Mental Illness through Law and Policy Reform. J Law Med Ethics. 2023; 51(2):355-362.
Improving Labor Outcomes among People with Mild or Moderate Mental Illness through Law and Policy Reform.
Investing in Certified Community Behavioral Health Centers to Fulfill Their Promise. Psychiatr Serv. 2024 Mar 01; 75(3):268-274.
Investing in Certified Community Behavioral Health Centers to Fulfill Their Promise.
The Strongest Predictor of CCBHC Presence: Population Density. Psychiatr Serv. 2024 Apr 01; 75(4):398.
The Strongest Predictor of CCBHC Presence: Population Density.
The Myth of the Free Market for Pharmaceuticals. N Engl J Med. 2024 04 25; 390(16):1448-1450.
The Myth of the Free Market for Pharmaceuticals.
Auditing the prescription drug consumer price index in a changing marketplace. Health Econ. 2024 08; 33(8):1793-1810.
Auditing the prescription drug consumer price index in a changing marketplace.
A holistic view of innovation incentives and pharmaceutical policy reform. Health Aff Sch. 2023 Jul; 1(1):qxad004.
A holistic view of innovation incentives and pharmaceutical policy reform.
Progress and Challenges in Medicaid-Financed Care of Substance Use Disorder. Am J Psychiatry. 2024 May 01; 181(5):359-361.
Progress and Challenges in Medicaid-Financed Care of Substance Use Disorder.
Mental health care reforms in Asia: the regional health care strategic plan: the growing impact of mental disorders in Japan. Psychiatr Serv. 2013 Jul 01; 64(7):617-9.
Mental health care reforms in Asia: the regional health care strategic plan: the growing impact of mental disorders in Japan.
The creation of Medicare and Medicaid: the emergence of insurance and markets for mental health services. Psychiatr Serv. 2000 Apr; 51(4):465-8.
The creation of Medicare and Medicaid: the emergence of insurance and markets for mental health services.
Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg A, Dow WH, Hui R, Frank R, Newhouse JP, Hsu J
Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs. Med Care. 2013 Jul; 51(7):614-21.
Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.
Assistant Professor of Population Medicine
Assessing the Effect of the Medicare Part D Redesign. JAMA. 2025 Feb 25; 333(8):663-664.
Assessing the Effect of the Medicare Part D Redesign.
Cognition and take-up of subsidized drug benefits by Medicare beneficiaries. JAMA Intern Med. 2013 Jun 24; 173(12):1100-7.
Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
The Evolution of Medicare: Challenges, Responses, and Prospects. J Health Polit Policy Law. 2025 Aug 01; 50(4):603-628.
The Evolution of Medicare: Challenges, Responses, and Prospects.
Mental Health Diagnoses Among Publicly Insured Children. JAMA. 2025 Jun 10; 333(22):1959-1961.
Mental Health Diagnoses Among Publicly Insured Children.
Chalkley M, Cutler D, Frank RG, Lleras-Muney A, Rice N, Siciliani L, Street AD
In recognition of Anthony J. Culyer. J Health Econ. 2013 Dec; 32(6):A1.
Helping (some) SSDI beneficiaries with severe mental illness return to work. Am J Psychiatry. 2013 Dec; 170(12):1379-81.
Helping (some) SSDI beneficiaries with severe mental illness return to work.
Recent Trends in Medication Treatment for Attention-Deficit Hyperactivity Disorder. Psychiatr Serv. 2025 Sep 01; 76(9):782-787.
Recent Trends in Medication Treatment for Attention-Deficit Hyperactivity Disorder.
Mental illness and violence: lessons from the evidence. Am J Public Health. 2014 Feb; 104(2):e5-6.
Mental illness and violence: lessons from the evidence.
Journal of social work in disability & rehabilitation
Behavioral health parity and the Affordable Care Act. J Soc Work Disabil Rehabil. 2014; 13(1-2):31-43.
Behavioral health parity and the Affordable Care Act.
Factors associated with high levels of spending for younger dually eligible beneficiaries with mental disorders. Health Aff (Millwood). 2014 Jun; 33(6):1006-13.
Factors associated with high levels of spending for younger dually eligible beneficiaries with mental disorders.
Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment. Focus (Am Psychiatr Publ). 2025 Jul; 23(3):362-369.
Nasir SA, Pandya D, Wojkiewicz S, Khandpur B, Downes E, Pathare P, Frank R
Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report. Cureus. 2022 Dec; 14(12):e32403.
Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report.
Adler L, Crow S, Fiedler M, Frank R, Fernandez R, Lake D, Braun RT
The changing landscape of primary care: an analysis of payer-primary care integration. Health Aff Sch. 2025 Jul; 3(7):qxaf120.
The changing landscape of primary care: an analysis of payer-primary care integration.
Correction: Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report. Cureus. 2022 Dec; 14(12):c85.
Correction: Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report.
The effects of wealth shocks on public and private long-term care insurance. J Health Econ. 2026 03; 106:103086.
The effects of wealth shocks on public and private long-term care insurance.
Enrollment in Medicare Advantage plans in Miami-Dade County: evidence of status quo bias? Inquiry. 2013 Aug; 50(3):202-15.
Enrollment in Medicare Advantage plans in Miami-Dade County: evidence of status quo bias?
The journal of behavioral health services & research
How the affordable care act and mental health parity and addiction equity act greatly expand coverage of behavioral health care. J Behav Health Serv Res. 2014 Oct; 41(4):410-28.
How the affordable care act and mental health parity and addiction equity act greatly expand coverage of behavioral health care.
The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction. 2014 Dec; 109(12):1957-8.
The Affordable Care Act will revolutionize care for substance use disorders in the United States.
Alders P, Costa-Font J, de Klerk M, Frank R
What is the impact of policy differences on nursing home utilization? The cases of Germany and the Netherlands. Health Policy. 2015 Jun; 119(6):814-20.
What is the impact of policy differences on nursing home utilization? The cases of Germany and the Netherlands.
Paying for Early Interventions in Psychoses: A Three-Part Model. Psychiatr Serv. 2015 Jul; 66(7):677-9.
Paying for Early Interventions in Psychoses: A Three-Part Model.
Busch AB, Epstein AM, McGuire TG, Normand SL, Frank RG
Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems. J Ment Health Policy Econ. 2015 Sep; 18(3):115-24.
Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.
Economics and the Transformation of the Mental Health System. J Health Polit Policy Law. 2016 Aug; 41(4):541-58.
Economics and the Transformation of the Mental Health System.
Mental Health Spending and Quality of Care
Operations Research and Economics in Mental Health
Health Policy Training Program: Promoting Outcomes, Quality, and Diffusion of Advances
Research Center on Managed Care and Drug Abuse Treatment
CONSEQUENCES OF COST CONTAINMENT POLICIES--MENTAL HEALTH
PRICE INDEXES OF MENTAL HEALTH TREATMENT
MARKETS FOR RESIDENTIAL/DAY TREATMENT PROGRAMS
Journal of economic behavior & organization
Dominated choices and Medicare Advantage enrollment. J Econ Behav Organ. 2015 Nov 01; 119:72-83.
Dominated choices and Medicare Advantage enrollment.
Care for the Vulnerable vs. Cash for the Powerful - Trump's Pick for HHS. N Engl J Med. 2017 Jan 12; 376(2):103-105.
Care for the Vulnerable vs. Cash for the Powerful - Trump's Pick for HHS.
Califf RM, Robb MA, Bindman AB, Briggs JP, Collins FS, Conway PH, Coster TS, Cunningham FE, De Lew N, DeSalvo KB, Dymek C, Dzau VJ, Fleurence RL, Frank RG, Gaziano JM, Kaufmann P, Lauer M, Marks PW, McGinnis JM, Richards C, Selby JV, Shulkin DJ, Shuren J, Slavitt AM, Smith SR, Washington BV, White PJ, Woodcock J, Woodson J, Sherman RE
Transforming Evidence Generation to Support Health and Health Care Decisions. N Engl J Med. 2016 Dec 15; 375(24):2395-2400.
Transforming Evidence Generation to Support Health and Health Care Decisions.
Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010 Jul; 9(7):560-74.
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.
Realizing the Promise of Parity Legislation for Mental Health. JAMA Psychiatry. 2017 02 01; 74(2):117-118.
Realizing the Promise of Parity Legislation for Mental Health.
Savings from drug discount cards: relief for Medicare beneficiaries? Health Aff (Millwood). 2004 Jan-Jun; Suppl Web Exclusives:W4-198-209.
Savings from drug discount cards: relief for Medicare beneficiaries?
Grabowski DC, Stevenson DG, Caudry DJ, O'Malley AJ, Green LH, Doherty JA, Frank RG
The Impact of Nursing Home Pay-for-Performance on Quality and Medicare Spending: Results from the Nursing Home Value-Based Purchasing Demonstration. Health Serv Res. 2017 08; 52(4):1387-1408.
The Impact of Nursing Home Pay-for-Performance on Quality and Medicare Spending: Results from the Nursing Home Value-Based Purchasing Demonstration.
Parity for mental health and substance abuse care under managed care. J Ment Health Policy Econ. 1998 Dec 01; 1(4):153-159.
Parity for mental health and substance abuse care under managed care.
Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM
Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005 Jun 16; 352(24):2515-23.
Prevalence and treatment of mental disorders, 1990 to 2003.
Measuring adverse selection in managed health care. J Health Econ. 2000 Nov; 19(6):829-54.
Measuring adverse selection in managed health care.
Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017 Feb 16; 376(7):605-607.
Addressing the Fentanyl Threat to Public Health.
Goldman HH, Frank RG, Burnam MA, Huskamp HA, Ridgely MS, Normand SL, Young AS, Barry CL, Azzone V, Busch AB, Azrin ST, Moran G, Lichtenstein C, Blasinsky M
Behavioral health insurance parity for federal employees. N Engl J Med. 2006 Mar 30; 354(13):1378-86.
Behavioral health insurance parity for federal employees.
Busch AB, Ling D, Frank RG, Greenfield SF
Changes in the quality of care for bipolar I disorder during the 1990s. Psychiatr Serv. 2007 Jan; 58(1):27-33.
Changes in the quality of care for bipolar I disorder during the 1990s.
Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM
Promotion of prescription drugs to consumers. N Engl J Med. 2002 Feb 14; 346(7):498-505.
Promotion of prescription drugs to consumers.
Prescription-drug prices. N Engl J Med. 2004 Sep 30; 351(14):1375-7.
Medical decision making : an international journal of the Society for Medical Decision Making
Using elicitation techniques to estimate the value of ambulatory treatments for major depression. Med Decis Making. 2002 May-Jun; 22(3):245-61.
Using elicitation techniques to estimate the value of ambulatory treatments for major depression.
Commentary: an economic perspective on implementing evidence-based depression care. Adm Policy Ment Health. 2006 Jan; 33(1):21-5.
Commentary: an economic perspective on implementing evidence-based depression care.
Rosenthal MB, Landon BE, Normand SL, Frank RG, Epstein AM
Pay for performance in commercial HMOs. N Engl J Med. 2006 Nov 02; 355(18):1895-902.
Evaluating selection out of health plans for Medicaid beneficiaries with substance abuse. J Behav Health Serv Res. 2003 Jan-Feb; 30(1):78-92.
Evaluating selection out of health plans for Medicaid beneficiaries with substance abuse.
Rosenthal MB, Frank RG, Buchanan JL, Epstein AM
Transmission of financial incentives to physicians by intermediary organizations in California. Health Aff (Millwood). 2002 Jul-Aug; 21(4):197-205.
Transmission of financial incentives to physicians by intermediary organizations in California.
Pincus HA, Hough L, Houtsinger JK, Rollman BL, Frank RG
International journal of methods in psychiatric research
Emerging models of depression care: multi-level ('6 P') strategies. Int J Methods Psychiatr Res. 2003; 12(1):54-63.
Emerging models of depression care: multi-level ('6 P') strategies.
Fung V, Price M, Busch A, Dow W, Fireman B, Hui R, Landrum MB, Frank R, Newhouse J, Hsu J
CB7-02: Medicare Part D Cost-sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems. Clin Med Res. 2012 Aug; 10(3):182.
CB7-02: Medicare Part D Cost-sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems.
Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr Serv. 2003 May; 54(5):682-7.
Aligning incentives in the treatment of depression in primary care with evidence-based practice.
Greenfield SF, Azzone V, Huskamp H, Cuffel B, Croghan T, Goldman W, Frank RG
Treatment for substance use disorders in a privately insured population under managed care: costs and services use. J Subst Abuse Treat. 2004 Dec; 27(4):265-75.
Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
Spending on substance abuse treatment: how much is enough? Addiction. 2005 Sep; 100(9):1240-8.
Spending on substance abuse treatment: how much is enough?
The ongoing regulation of generic drugs. N Engl J Med. 2007 Nov 15; 357(20):1993-6.
The ongoing regulation of generic drugs.
New estimates of drug development costs. J Health Econ. 2003 Mar; 22(2):325-30.
New estimates of drug development costs.
Landon BE, Normand SL, Meara E, Simon SR, Frank R, McNeil BJ
The relationship between medical practice characteristics and quality of care for cardiovascular disease. Med Care Res Rev. 2008 Apr; 65(2):167-86.
The relationship between medical practice characteristics and quality of care for cardiovascular disease.
Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RG
Generic entry, reformulations and promotion of SSRIs in the US. Pharmacoeconomics. 2008; 26(7):603-16.
Generic entry, reformulations and promotion of SSRIs in the US.
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion. Med Care. 2010 Apr; 48(4):372-9.
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.
Berndt ER, Bir A, Busch SH, Frank RG, Normand SL
The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes. J Health Econ. 2002 May; 21(3):373-96.
The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes.
Landon BE, Normand SL, Frank R, McNeil BJ
Characteristics of medical practices in three developed managed care markets. Health Serv Res. 2005 Jun; 40(3):675-95.
Characteristics of medical practices in three developed managed care markets.
Mental health policy and psychotropic drugs. Milbank Q. 2005; 83(2):271-98.
Mental health policy and psychotropic drugs.
Timbie JW, Horvitz-Lennon M, Frank RG, Normand SL
A meta-analysis of labor supply effects of interventions for major depressive disorder. Psychiatr Serv. 2006 Feb; 57(2):212-8.
A meta-analysis of labor supply effects of interventions for major depressive disorder.
Managed behavioral health care carve-outs: past performance and future prospects. Annu Rev Public Health. 2007; 28:303-20.
Managed behavioral health care carve-outs: past performance and future prospects.
Rosenthal MB, Landon BE, Normand SL, Frank RG, Ahmad TS, Epstein AM
Employers' use of value-based purchasing strategies. JAMA. 2007 Nov 21; 298(19):2281-8.
Employers' use of value-based purchasing strategies.
Blais MA, Frank RG, Nierenberg AA, Rauch SL
Measuring outcomes makes good sense. Psychiatr Serv. 2009 Jan; 60(1):112.
Busch AB, Huskamp HA, Normand SL, Young AS, Goldman H, Frank RG
The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation. Med Care. 2006 Jun; 44(6):506-12.
The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation.
The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia. Arch Gen Psychiatry. 2004 May; 61(5):442-8.
The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
Health care reform and mental health care delivery. Psychiatr Serv. 2010 Nov; 61(11):1063.
Health care reform and mental health care delivery.
Horvitz-Lennon M, O'Malley AJ, Frank RG, Normand SL
Improving traditional intention-to-treat analyses: a new approach. Psychol Med. 2005 Jul; 35(7):961-70.
Improving traditional intention-to-treat analyses: a new approach.
Azrin ST, Huskamp HA, Azzone V, Goldman HH, Frank RG, Burnam MA, Normand SL, Ridgely MS, Young AS, Barry CL, Busch AB, Moran G
Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics. 2007 Feb; 119(2):e452-9.
Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program.
Was Part D a giveaway to the pharmaceutical industry? Inquiry. 2007; 44(1):15-25.
Was Part D a giveaway to the pharmaceutical industry?
Using shared savings to foster coordinated care for dual eligibles. N Engl J Med. 2013 Jan 31; 368(5):404-5.
Using shared savings to foster coordinated care for dual eligibles.
Private long-term care insurance and state tax incentives. Inquiry. 2009; 46(3):305-21.
Private long-term care insurance and state tax incentives.
Regulated Medicare Advantage And Marketplace Individual Health Insurance Markets Rely On Insurer Competition. Health Aff (Millwood). 2017 09 01; 36(9):1578-1584.
Regulated Medicare Advantage And Marketplace Individual Health Insurance Markets Rely On Insurer Competition.
Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG
The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003 Dec 04; 349(23):2224-32.
The effect of incentive-based formularies on prescription-drug utilization and spending.
Talbott and financing policy: Reducing fragmentation. Psychiatr Serv. 2004 Oct; 55(10):1150-1.
Talbott and financing policy: Reducing fragmentation.
Policy toward second-generation antipsychotic drugs: a cautionary note. Psychiatr Serv. 2008 May; 59(5):521-2.
Policy toward second-generation antipsychotic drugs: a cautionary note.
Bauer AM, Azzone V, Alexander L, Goldman HH, Unützer J, Frank RG
Are patient characteristics associated with quality of depression care and outcomes in collaborative care programs for depression? Gen Hosp Psychiatry. 2012 Jan-Feb; 34(1):1-8.
Are patient characteristics associated with quality of depression care and outcomes in collaborative care programs for depression?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop. J Nucl Med. 2012 02; 53(2):336-42.
New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop.
Grabowski DC, Joyce NR, McGuire TG, Frank RG
Passive Enrollment Of Dual-Eligible Beneficiaries Into Medicare And Medicaid Managed Care Has Not Met Expectations. Health Aff (Millwood). 2017 05 01; 36(5):846-854.
Passive Enrollment Of Dual-Eligible Beneficiaries Into Medicare And Medicaid Managed Care Has Not Met Expectations.
Economic grand rounds: economics and the Surgeon General's Report on Mental Health. Psychiatr Serv. 2002 Apr; 53(4):409-11.
Economic grand rounds: economics and the Surgeon General's Report on Mental Health.
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004 Dec; 42(12):1176-85.
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.
Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Arch Gen Psychiatry. 2005 Apr; 62(4):435-41.
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
Barry CL, Gabel JR, Frank RG, Hawkins S, Whitmore HH, Pickreign JD
Design of mental health benefits: still unequal after all these years. Health Aff (Millwood). 2003 Sep-Oct; 22(5):127-37.
Design of mental health benefits: still unequal after all these years.
Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices. J Health Econ. 2007 Dec 01; 26(6):1101-27.
Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices.
Bipolar-I depression outpatient treatment quality and costs in usual care practice. Psychopharmacol Bull. 2008; 41(2):24-39.
Bipolar-I depression outpatient treatment quality and costs in usual care practice.
Barry CL, Goldman HH, Frank RG, Huskamp HA
Lessons for healthcare reform from the hard-won success of behavioral health insurance parity. Am J Psychiatry. 2009 Sep; 166(9):969-71.
Lessons for healthcare reform from the hard-won success of behavioral health insurance parity.
Demand response of mental health services to cost sharing under managed care. J Ment Health Policy Econ. 2008 Sep; 11(3):113-25.
Demand response of mental health services to cost sharing under managed care.
Rosenthal MB, Frank RG, Li Z, Epstein AM
Early experience with pay-for-performance: from concept to practice. JAMA. 2005 Oct 12; 294(14):1788-93.
Early experience with pay-for-performance: from concept to practice.
Depression in primary care: quality improvement and economics. Manag Care. 2008 Mar; 17(3 Suppl 2):22-4; discussion 25-6.
Depression in primary care: quality improvement and economics.
Medicaid and mental health: be careful what you ask for. Health Aff (Millwood). 2003 Jan-Feb; 22(1):101-13.
Medicaid and mental health: be careful what you ask for.
The diffusion of new antipsychotic medications and formulary policy. Schizophr Bull. 2003; 29(1):95-104.
The diffusion of new antipsychotic medications and formulary policy.
Characterizing declines in pediatric antidepressant use after new risk disclosures. Med Care Res Rev. 2011 Feb; 68(1):96-111.
Characterizing declines in pediatric antidepressant use after new risk disclosures.
Slowing Medicare spending growth: reaching for common ground. Am J Manag Care. 2012 08; 18(8):465-8.
Slowing Medicare spending growth: reaching for common ground.
Israel journal of health policy research
Beyond the trends: policy considerations in psychiatric rehabilitation. Isr J Health Policy Res. 2012 Jun 20; 1(1):25.
Beyond the trends: policy considerations in psychiatric rehabilitation.
The evolving private psychiatric inpatient market. J Behav Health Serv Res. 2011 Jan; 38(1):122-31.
The evolving private psychiatric inpatient market.
Busch SH, Frank RG, Leslie DL, Martin A, Rosenheck RA, Martin EG, Barry CL
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns? Psychiatr Serv. 2010 Jan; 61(1):11-6.
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
Mental health in the mainstream of health care. Health Aff (Millwood). 2007 Nov-Dec; 26(6):1539-41.
Mental health in the mainstream of health care.
Should drug prices be negotiated under part D of Medicare? And if so, how? Health Aff (Millwood). 2008 Jan-Feb; 27(1):33-43.
Should drug prices be negotiated under part D of Medicare? And if so, how?
Goetzel RZ, Roemer EC, Holingue C, Fallin MD, McCleary K, Eaton W, Agnew J, Azocar F, Ballard D, Bartlett J, Braga M, Conway H, Crighton KA, Frank R, Jinnett K, Keller-Greene D, Rauch SM, Safeer R, Saporito D, Schill A, Shern D, Strecher V, Wald P, Wang P, Mattingly CR
Journal of occupational and environmental medicine
Mental Health in the Workplace: A Call to Action Proceedings From the Mental Health in the Workplace-Public Health Summit. J Occup Environ Med. 2018 04; 60(4):322-330.
Mental Health in the Workplace: A Call to Action Proceedings From the Mental Health in the Workplace-Public Health Summit.
Fullerton CA, Epstein AM, Frank RG, Normand SL, Fu CX, McGuire TG
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005. Psychiatr Serv. 2012 Feb 01; 63(2):115-21.
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
Medicare drug prices and the deficit. N Engl J Med. 2011 Nov 03; 365(18):1657-9.
Shapiro GI, Frank R, Dandamudi UB, Hengelage T, Zhao L, Gazi L, Porro MG, Woo MM, Lewis LD
The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer. Cancer Chemother Pharmacol. 2012 Feb; 69(2):555-62.
The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer.
Hodgkin D, Volpe-Vartanian J, Merrick EL, Horgan CM, Nierenberg AA, Frank RG, Lee S
Customization in prescribing for bipolar disorder. Health Econ. 2012 Jun; 21(6):653-68.
Customization in prescribing for bipolar disorder.
Can you get what you pay for? Pay-for-performance and the quality of healthcare providers. Rand J Econ. 2010; 41(1):64-91.
Can you get what you pay for? Pay-for-performance and the quality of healthcare providers.
Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ
Behavioral health services for women who have breast cancer. J Clin Oncol. 2009 Feb 10; 27(5):706-12.
Behavioral health services for women who have breast cancer.
The costs of mental health parity: still an impediment? Health Aff (Millwood). 2006 May-Jun; 25(3):623-34.
The costs of mental health parity: still an impediment?
Frank RG, Pindyck T, Donahue SA, Pease EA, Foster MJ, Felton CJ, Essock SM
Impact of a media campaign for disaster mental health counseling in post-September 11 New York. Psychiatr Serv. 2006 Sep; 57(9):1304-8.
Impact of a media campaign for disaster mental health counseling in post-September 11 New York.